SEC Form 4 · accession 0001169897-26-000003
SELECT MEDICAL HOLDINGS CORP · SEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David S Chernow
Officer — VICE CHAIRMAN · Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 1, 2026 · 2:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001320414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 30, 2026 | J | 100,000 | $0.00 | D | 777,244 | D | |
| Common StockF3 | Jun 30, 2026 | D | 656,823 | $16.50 | D | 113,421 | D | |
| Common Stock | Jun 30, 2026 | F | 113,421 | $16.50 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).
- F2Immediately prior to the effective time of the merger, the Reporting Person contributed 100,000 restricted shares to Parent in exchange for an equivalent amount of restricted shares of Parent, which restricted shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
- F3At the effective time of the merger, each of the Reporting Person's shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").
- F4Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.